Severe toxicity of fialuridine (FIAU) [2]

New England Journal of Medicine

Volumn 334, Issue 17, 1996, Pages 1135-1138

  Bari, A ^a   Josephson, L ^a   Prince, A M ^a   Lewis, W ^a   Perrino, F W ^a   Gordon, M ^a   Hoofnagle, J ^a   McKenzie, R ^a   Straus, S ^a   Swartz, M N ^a   Stotka, J L ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLEVUDINE; DNA DIRECTED DNA POLYMERASE GAMMA; FIACITABINE; FIALURIDINE; INTERFERON; MITOCHONDRIAL DNA; NUCLEOSIDE ANALOG; ANTIVIRUS AGENT; DRUG DERIVATIVE; NUCLEOSIDE; URACIL ARABINOSIDE;

BONE MARROW SUPPRESSION; CHRONIC HEPATITIS; CLINICAL TRIAL; DRUG APPROVAL; HEPATITIS B; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LACTIC ACIDOSIS; LETTER; LIVER FAILURE; MITOCHONDRION; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TISSUE INJURY; CHRONIC DISEASE; NOTE; ANIMAL; DRUG SCREENING; HEPATITIS; METHODOLOGY; SCIURIDAE;

ANTIVIRAL AGENTS; ARABINOFURANOSYLURACIL; CHRONIC DISEASE; HEPATITIS B; HUMANS; INTERFERONS; NUCLEOSIDES; ANIMALS; DRUG EVALUATION, PRECLINICAL; HEPATITIS; MARMOTA;

EID: 0029935623     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199604253341715     Document Type: Letter

References (0)